词条 | Epigenomics (journal) |
释义 |
| title = Epigenomics | cover = | former_name = | abbreviation = Epigenomics | discipline = Epigenomics | editor = James G. Herman, Jörg Tost | publisher = Future Medicine Ltd | country = | history = 2009–present | frequency = 12/year | openaccess = | license = | impact = 4.979 | impact-year = 2017 | ISSN = 1750-1911 | eISSN = 1750-192X | CODEN = EPIGC7 | JSTOR = | LCCN = | OCLC = 746948365 | website = http://www.futuremedicine.com/loi/epi | link1 = | link1-name = | link2 = | link2-name = }} Epigenomics is a peer-reviewed medical journal established in 2009 and published by Future Medicine. The editors-in-chief are James G. Herman (University of Pittsburgh Cancer Institute) and Jörg Tost ({{Interlanguage link multi|Centre national de génotypage|fr}}). The journal covers all aspects of research on epigenomics and epigenetics and their implications for diagnosis, prognosis and therapeutics. Abstracting and indexingThe journal is abstracted and indexed in EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Chemical Abstracts, BIOSIS Previews, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2017 impact factor of 4.979, ranking it 31st out of 166 journals in the category "Genetics & Heredity".[1] References1. ^{{cite book |year=2017 |chapter=Journals Ranked by Impact: Genetics & Heredity |title=2016 Journal Citation Reports |publisher=Thomson Reuters |edition=Science |series=Web of Science}} External links
5 : Publications established in 2009|Medical genetics journals|English-language journals|Epigenetics|Future Science Group academic journals |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。